Novo CEO pressed by Senate to cut price ranges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen explained to lawmakers the company would take into account new talks with insurers concerning the record costs of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Insurers will https://busch-light-peach-calorie19752.thezenweb.com/the-smart-trick-of-healthcare-news-that-no-one-is-discussing-68505574